Avanos Medical Inc (AVNS) Receives a Hold from Barclays

In a report released yesterday, Kristen Stewart from Barclays maintained a Hold rating on Avanos Medical Inc (AVNS), with a price target of $59. The company’s shares closed yesterday at $50.61.

According to TipRanks.com, Stewart is a 3-star analyst with an average return of 3.2% and a 72.5% success rate. Stewart covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Baxter International.

Currently, the analyst consensus on Avanos Medical Inc is a Hold with an average price target of $61.33.

See today’s analyst top recommended stocks >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Avanos Medical, Inc. is a medical technology company focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. It operates through the following business segments: Surgical & Infection Prevention and Medical Devices.